One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease

A Randomized Study of the Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in Treatment of Moderate to Severe Dry Eye

(2017) Christophe Baudouin et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Pan-European survey of the topical ocular use of cyclosporine A

(2017) A. Labbé et al.   JOURNAL FRANCAIS D OPHTALMOLOGIE

Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease: A Multicenter Randomized Trial

(2016) Andrea Leonardi et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease

(2013) Seth P. Epstein et al.   EXPERIMENTAL EYE RESEARCH

Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery

(2013) Philippe Daull et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Role of Hyperosmolarity in the Pathogenesis and Management of Dry Eye Disease: Proceedings of the OCEAN Group Meeting

(2013) Christophe Baudouin et al.   Ocular Surface

Distribution of Cyclosporine A in Ocular Tissues After Topical Administration of Cyclosporine A Cationic Emulsions to Pigmented Rabbits

(2012) Philippe Daull et al.   CORNEA

Dry Eye Disease

(2010) Fabiana de Pinho Tavares et al.   Seminars in Ophthalmology

Immunosuppressive therapy for ocular diseases

(2008) Aliza Jap et al.   CURRENT OPINION IN OPHTHALMOLOGY